Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
Uchini S. Kosgodage(London Metropolitan University), Sigrun Lange(University College London), Jameel M. Inal(London Metropolitan University), Rhys R. Mould(University of Westminster), Geoffrey W. Guy(GW Pharmaceuticals (United Kingdom)), E. Louise Thomas(Hammersmith Hospital), Aine Brigette Henley(University of Westminster), Jimmy D. Bell(Imperial College London), Alistair V.W. Nunn(University of Westminster)
Cited by 145
Related Papers
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
|Nature Communications|2014|1.7k
Critical role for peptide YY in protein-mediated satiation and body-weight regulation
|Cell Metabolism|2006|623
Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-γ
|Diabetes|2003|429